Home > Healthcare > Medical Devices > Diagnostic Devices > Respiratory Disease Testing Market
Respiratory Disease Testing Market Size
- Report ID: GMI1871
- Published Date: Apr 2023
- Report Format: PDF
Respiratory Disease Testing Market Size
Respiratory Disease Testing Market size was worth USD 14 billion in 2022 and is anticipated to exhibit 6.5% CAGR from 2023-2032. Rising burden of pulmonary and hospital-acquired infections is likely to favor market dynamics.
The growing number of government-led initiatives, specifically in the developed and developing regions will complement the market expansion. Several government bodies are coming up with awareness programs for educating the mass population about various respiratory disorders and their prevention. To illustrate, the National Heart, Lung, and Blood Institute introduced the COPD Learn More Breathe Better (LMBB) campaign for instigating higher awareness along with educating the public regarding COPD (chronic obstructive pulmonary diseases). The campaign is also directed at offering early detection and treatment to individuals affected by various lung diseases.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Respiratory Disease Testing Market Size in 2022: | USD 14 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 6.5% |
| 2032 Value Projection: | USD 26 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 446 |
| Tables, Charts & Figures: | 202 |
| Segments covered: | Test Type, Application, End use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Respiratory Disease Testing Market Scope
